613 related articles for article (PubMed ID: 30992053)
1. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.
Abdel-Wahab N; Safa H; Abudayyeh A; Johnson DH; Trinh VA; Zobniw CM; Lin H; Wong MK; Abdelrahim M; Gaber AO; Suarez-Almazor ME; Diab A
J Immunother Cancer; 2019 Apr; 7(1):106. PubMed ID: 30992053
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitors in Organ Transplant Patients.
Kittai AS; Oldham H; Cetnar J; Taylor M
J Immunother; 2017 Sep; 40(7):277-281. PubMed ID: 28719552
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?
De Bruyn P; Van Gestel D; Ost P; Kruse V; Brochez L; Van Vlierberghe H; Devresse A; Del Marmol V; Le Moine A; Aspeslagh S
Curr Opin Oncol; 2019 Mar; 31(2):54-64. PubMed ID: 30694841
[TBL] [Abstract][Full Text] [Related]
4. A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
Tsung I; Worden FP; Fontana RJ
Oncologist; 2021 Feb; 26(2):133-138. PubMed ID: 32969143
[TBL] [Abstract][Full Text] [Related]
5. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
Smedman TM; Line PD; Guren TK; Dueland S
Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
[No Abstract] [Full Text] [Related]
6. Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient.
Herz S; Höfer T; Papapanagiotou M; Leyh JC; Meyenburg S; Schadendorf D; Ugurel S; Roesch A; Livingstone E; Schilling B; Franklin C
Eur J Cancer; 2016 Nov; 67():66-72. PubMed ID: 27614165
[TBL] [Abstract][Full Text] [Related]
7. Liver graft rejection following immune checkpoint inhibitors treatment: a review.
Hu B; Yang XB; Sang XT
Med Oncol; 2019 Oct; 36(11):94. PubMed ID: 31605245
[TBL] [Abstract][Full Text] [Related]
8. Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment.
Abu-Sbeih H; Tran CN; Ge PS; Bhutani MS; Alasadi M; Naing A; Jazaeri AA; Wang Y
J Immunother Cancer; 2019 May; 7(1):118. PubMed ID: 31053161
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.
Ong M; Ibrahim AM; Bourassa-Blanchette S; Canil C; Fairhead T; Knoll G
J Immunother Cancer; 2016; 4():64. PubMed ID: 27777773
[TBL] [Abstract][Full Text] [Related]
10. Role of Checkpoint Inhibition in Localized Bladder Cancer.
Hahn NM; Necchi A; Loriot Y; Powles T; Plimack ER; Sonpavde G; Roupret M; Kamat AM
Eur Urol Oncol; 2018 Aug; 1(3):190-198. PubMed ID: 31102620
[TBL] [Abstract][Full Text] [Related]
11. Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis.
Abu-Sbeih H; Ali FS; Wang X; Mallepally N; Chen E; Altan M; Bresalier RS; Charabaty A; Dadu R; Jazaeri A; Lashner B; Wang Y
J Immunother Cancer; 2019 Apr; 7(1):93. PubMed ID: 30940209
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort.
Remon J; Auclin E; Zubiri L; Schneider S; Rodriguez-Abreu D; Minatta N; Gautschi O; Aboubakar F; Muñoz-Couselo E; Pierret T; Rothschild SI; Cortiula F; Reynolds KL; Thibault C; Gavralidis A; Blais N; Barlesi F; Planchard D; Besse BMD
ESMO Open; 2024 May; 9(5):103004. PubMed ID: 38653155
[TBL] [Abstract][Full Text] [Related]
13. Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?
Lai HC; Lin JF; Hwang TIS; Liu YF; Yang AH; Wu CK
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31058839
[TBL] [Abstract][Full Text] [Related]
14. Checkpoint blockade after kidney transplantation.
Lesouhaitier M; Dudreuilh C; Tamain M; Kanaan N; Bailly E; Legoupil D; Deltombe C; Perrin P; Manson G; Vigneau C; Houot R
Eur J Cancer; 2018 Jun; 96():111-114. PubMed ID: 29705511
[No Abstract] [Full Text] [Related]
15. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review.
d'Izarny-Gargas T; Durrbach A; Zaidan M
Am J Transplant; 2020 Sep; 20(9):2457-2465. PubMed ID: 32027461
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis.
Owoyemi I; Vaughan LE; Costello CM; Thongprayoon C; Markovic SN; Herrmann J; Otley CC; Taner T; Mangold AR; Leung N; Herrmann SM; Kukla A
Cancer; 2020 Nov; 126(21):4780-4787. PubMed ID: 32786022
[TBL] [Abstract][Full Text] [Related]
18. The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.
Kumar V; Shinagare AB; Rennke HG; Ghai S; Lorch JH; Ott PA; Rahma OE
Oncologist; 2020 Jun; 25(6):505-514. PubMed ID: 32043699
[TBL] [Abstract][Full Text] [Related]
19. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience.
Mamlouk O; Selamet U; Machado S; Abdelrahim M; Glass WF; Tchakarov A; Gaber L; Lahoti A; Workeneh B; Chen S; Lin J; Abdel-Wahab N; Tayar J; Lu H; Suarez-Almazor M; Tannir N; Yee C; Diab A; Abudayyeh A
J Immunother Cancer; 2019 Jan; 7(1):2. PubMed ID: 30612580
[TBL] [Abstract][Full Text] [Related]
20. Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma.
Spain L; Higgins R; Gopalakrishnan K; Turajlic S; Gore M; Larkin J
Ann Oncol; 2016 Jun; 27(6):1135-1137. PubMed ID: 26951628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]